Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Merck

company

About

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$5M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 1891
Number Of Employee
10001 - max
Operating Status
Active
Stock Symbol
nyse:MRK
Legal Name
Merck & Co., Inc.

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

The company is driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. Merck delivers vaccines, medications, and consumer and animal health products that can help millions around the world.

Merck was founded in 1891 and is headquartered in Kenilworth, NJ.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$5.58M
Merck has raised a total of $5.58M in funding over 2 rounds. Their latest funding was raised on Nov 25, 2018 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 25, 2018 Post-IPO Equity $586K 1 Private Capital Advisors Detail
Jan 21, 2016 Series Unknown $5M 1 Gavi, the Vaccine Alliance Detail
Dec 19, 1980 IPO Detail

Investments

Number of Investments
Number of Lead Investments
27
5
Merck has made 27 investments. Their most recent investment was on Jun 2, 2022, when Canonical Crypto raised $20M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 2, 2022 Canonical Crypto
Series Unknown $20M Blockchain
Mar 30, 2022 Qure AI
Series C $40M Artificial Intelligence
Sep 14, 2020 Seagen
Post-IPO Equity $1B Biotechnology Yes
Aug 28, 2020 Zapata Computing
Series B $2.95M Computer
Series B $14M Biotechnology

Investors

Number of Lead Investors
Number of Investors
2
2
Merck is funded by 2 investors. Private Capital Advisors and Gavi, the Vaccine Alliance are the most recent investors.
Investor Name Lead Investor Funding Round
Private Capital Advisors Yes Post-IPO Equity
Gavi, the Vaccine Alliance Yes Series Unknown

Employee Profiles

Number of Employee Profiles
105
Merck has 105 current employee profiles, including Employee Thomas Glocer
Employee
Employee
Executive
Employee
Employee

Exits

Merck has had 9 exits. Merck most notable exits include SAB Biotherapeutics ,   Themis Bioscience

Date Company Name Exit Type Industry
Oct 25, 2021 SAB Biotherapeutics IPO Biotechnology Detail
May 26, 2020 Themis Bioscience M&A Biotechnology Detail
May 20, 2019 Just - Evotec Biologics M&A Biotechnology Detail
Apr 4, 2019 NGM Biopharmaceuticals IPO Biopharma Detail
Jan 2, 2019 Hangzhou Just Biotherapeutics (Just China) M&A Biopharma Detail

Acquisition

Merck has acquired 33 organizations. Their most recent acquisition was Medco Containment Services Inc. on Nov 19, 1993. They acquired Medco Containment Services Inc. for $6M.

Date Company Name
Industry Acquisition Type Price
Health Care acquisition $ 6M Detail
May 9, 2006 GlycoFi Inc.
Biotechnology acquisition $ 400M Detail
Biotechnology acquisition $ 1.10B Detail
Nov 9, 2006 Abmaxis, Inc.
Biotechnology acquisition $ 80M Detail
Jul 25, 2007 NovaCardia
Biotechnology acquisition $ 366.40M Detail